NEW YORK, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Sema4 Holdings Corp. ("Sema4” or the "Company”) (Nasdaq: SMFR; SMFRW).
If you are an investor of Sema4 and would like to discuss our investigation, please contact us by emailing pmayer@kaplanfox.com or by calling (646) 315-9003.
Sema4 is an artificial intelligence and machine learning-driven health intelligence company that went public through a business combination with CM Life Sciences (Nasdaq: CMLF), a special purpose acquisition company, or SPAC. The business combination was announced on February 10, 2021 and closed on or about July 22, 2021. Sema4 common stock and warrants began trading on the Nasdaq Global Select Market on July 23, 2021.
On June 14, 2022, less than a year after the business combination, Sema4 announced the departure of its Chief Financial Officer, Isaac Ro, effective immediately.
Then, on August 15, 2022 after the market closed, Sema4 issued a press release announcing changes to its research and development leadership team, including that Sema4’s Founder, Eric Schadt, was stepping down from the organization, including his role as President & Chief R&D Officer. Sema4 also issued a second press release on August 15, 2022 announcing a series of restructuring and corporate realignments, including the elimination of 250 positions, representing approximately 13% of its workforce. The Company also lowered its fiscal 2022 revenue guidance to $245 million to $255 million, compared to its prior guidance of $305 million to $315 million.
Following these disclosures, the price of Sema4’s stock fell over 33% to close at $1.60 per share on August 16, 2022.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, San Francisco, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com.
If you have any questions about this investigation, your rights, or your interests, please contact:
Donald R Hall
KAPLAN FOX & KILSHEIMER LLP
850 Third Avenue, 14th Floor
New York, New York 10022
(646) 315-9003
E-mail: dhall@kaplanfox.com
Laurence D. King
KAPLAN FOX & KILSHEIMER LLP
1999 Harrison Street, Suite 1560
Oakland, California 94612
(415) 772-4704
Fax: (415) 772-4707
E-mail: lking@kaplanfox.com
